Harbour Investments Inc. raised its position in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 174.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,447 shares of the company’s stock after buying an additional 2,193 shares during the period. Harbour Investments Inc.’s holdings in Cardinal Health were worth $579,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Principal Financial Group Inc. lifted its position in shares of Cardinal Health by 5.3% during the first quarter. Principal Financial Group Inc. now owns 315,817 shares of the company’s stock worth $43,510,000 after purchasing an additional 15,956 shares in the last quarter. Kingswood Wealth Advisors LLC lifted its position in shares of Cardinal Health by 17.2% during the first quarter. Kingswood Wealth Advisors LLC now owns 3,119 shares of the company’s stock worth $429,000 after purchasing an additional 457 shares in the last quarter. Golden State Wealth Management LLC lifted its position in shares of Cardinal Health by 569.5% during the first quarter. Golden State Wealth Management LLC now owns 395 shares of the company’s stock worth $54,000 after purchasing an additional 336 shares in the last quarter. North Capital Inc. acquired a new position in shares of Cardinal Health during the first quarter worth approximately $83,000. Finally, KLP Kapitalforvaltning AS lifted its position in shares of Cardinal Health by 4.0% during the second quarter. KLP Kapitalforvaltning AS now owns 114,198 shares of the company’s stock worth $19,185,000 after purchasing an additional 4,400 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities analysts have recently issued reports on CAH shares. Leerink Partners upped their target price on shares of Cardinal Health from $186.00 to $187.00 and gave the stock an “outperform” rating in a research report on Monday, October 6th. Robert W. Baird upped their target price on shares of Cardinal Health from $197.00 to $203.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 13th. Wall Street Zen lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 2nd. UBS Group restated a “buy” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Finally, Evercore ISI cut their price objective on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating on the stock in a report on Wednesday, August 13th. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and an average target price of $166.00.
Insider Activity at Cardinal Health
In other news, insider Jessica L. Mayer sold 38,078 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the transaction, the insider directly owned 48,457 shares of the company’s stock, valued at $7,211,370.74. This trade represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Michelle D. Greene sold 13,500 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the transaction, the insider directly owned 14,976 shares in the company, valued at approximately $2,228,728.32. This represents a 47.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 271,676 shares of company stock valued at $40,489,525. 0.12% of the stock is owned by corporate insiders.
Cardinal Health Stock Performance
CAH opened at $156.29 on Monday. The firm’s fifty day moving average is $151.88 and its two-hundred day moving average is $151.91. The firm has a market cap of $37.13 billion, a PE ratio of 24.23, a price-to-earnings-growth ratio of 1.32 and a beta of 0.71. Cardinal Health, Inc. has a twelve month low of $106.98 and a twelve month high of $168.44.
Cardinal Health (NYSE:CAH – Get Free Report) last announced its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. The company had revenue of $60.16 billion for the quarter, compared to analysts’ expectations of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business’s quarterly revenue was up .5% compared to the same quarter last year. During the same period last year, the firm posted $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.
Cardinal Health Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st were given a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date of this dividend was Wednesday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is currently 31.63%.
About Cardinal Health
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Articles
- Five stocks we like better than Cardinal Health
- What is a Dividend King?
- JPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?
- What is a Microcap Stock? Everything You Need to Know
- Snap-on Incorporated: Snap It Up Quick, New Highs Will Come Soon
- How to start investing in penny stocks
- As Global Renewables Surpass Coal, This ETF Offers Smart Exposure
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.